Toru Sakamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toru Sakamoto has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chiyoko Tanamachi
Department of Clinical Laboratory Medicine, Kurume University Hospital
1 shared publication - Hiroshi Watanabe
Department of Infection Control and Prevention, Kurume University School of Medicine, Kurume 830-0011, Japan
1 shared publication - Kenji Gotoh
Department of Infection Control and Prevention, Kurume University School of Medicine, Kurume 830-0011, Japan
1 shared publication - Kenyu Hashimoto
Department of Clinical Investigation Kumamoto University Hospital Kumamoto Japan
1 shared publication
Latest Publications
- Open Access
- 11 May 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (5) , 497
Risk Factors and Clinical Characteristics of Patients with Ocular Candidiasis
Ocular candidiasis is a critical and challenging complication of candidemia. The purpose of this study was to investigate the appropriate timing for ophthalmologic examinations, risk factors for complications of ocular lesions, and their association with mortality. This retrospective cohort study applied, using multiple logistic regression analysis and Cox regression models, to cases of candidemia (age ≥ 18 years) for patients who underwent ophthalmologic consultation. Of the 108 candidemia patients who underwent ophthalmologic examination, 27 (25%) contracted patients had ocular candidiasis, and 7 experienced the more severe condition of endophthalmitis, which included subjective ocular symptoms. In most cases, the initial ophthalmologic examination was performed within one week of the onset of candidiasis with a diagnosis of ocular candidiasis, but in three cases, the findings became apparent only after a second examination within 7–14 days after onset of candidiasis. The independent risk factor extracted for the development of ocular candidiasis was the isolation of C. albicans (OR, 4.85; 95% CI, 1.58–14.90), unremoved CVC (OR, 10.40; 95% CI, 1.74–62.16), and a high βDG value (>108.2 pg/mL) (HR, 2.83; 95% CI = 1.24–6.27). Continuous ophthalmologic examination is recommended in cases of candidemia with the above risk factors with an initial examination within 7 days of onset and a second examination 7–14 days after onset.
- 11 May 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (5) , 497
Open AccessRisk Factors and Clinical Characteristics of Patients with Ocular Candidiasis
Ocular candidiasis is a critical and challenging complication of candidemia. The purpose of this study was to investigate the appropriate timing for ophthalmologic examinations, risk factors for complications of ocular lesions, and their association with mortality. This retrospective cohort study applied, using multiple logistic regression analysis and Cox regression models, to cases of candidemia (age ≥ 18 years) for patients who underwent ophthalmologic consultation. Of the 108 candidemia patients who underwent ophthalmologic examination, 27 (25%) contracted patients had ocular candidiasis, and 7 experienced the more severe condition of endophthalmitis, which included subjective ocular symptoms. In most cases, the initial ophthalmologic examination was performed within one week of the onset of candidiasis with a diagnosis of ocular candidiasis, but in three cases, the findings became apparent only after a second examination within 7–14 days after onset of candidiasis. The independent risk factor extracted for the development of ocular candidiasis was the isolation of C. albicans (OR, 4.85; 95% CI, 1.58–14.90), unremoved CVC (OR, 10.40; 95% CI, 1.74–62.16), and a high βDG value (>108.2 pg/mL) (HR, 2.83; 95% CI = 1.24–6.27). Continuous ophthalmologic examination is recommended in cases of candidemia with the above risk factors with an initial examination within 7 days of onset and a second examination 7–14 days after onset.